StreetInsider.com News Articles

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Fri, 17 Jul 2026 17:15:00 -0400

SAN CARLOS, Calif., July 17, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on July 16, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 139,930 shares of Iovance’s common stock to seventeen new, non-executive employees.

The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees of

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Fri, 17 Jul 2026 17:15:00 -0400

The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees of

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 30

Thu, 02 Jul 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260702/26729250.html

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 30

Thu, 02 Jul 2026 17:02:00 -0400

si-local-file:///var/storage/secattach/20260702/26729250.html

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Fri, 19 Jun 2026 17:15:00 -0400

SAN CARLOS, Calif., June 19, 2026 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (“TIL”) therapies for patients with cancer, today announced that on June 18, 2026 (the “Date of Grant”), the Company approved the grant of inducement stock options covering an aggregate of 140,860 shares of Iovance’s common stock to twenty-seven new, non-executive employees.

The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

Fri, 19 Jun 2026 17:15:00 -0400

The awards were granted under Iovance’s Amended and Restated 2021 Inducement Plan, which provides for the granting of equity awards to new employees

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Dukes Iain D.

Thu, 18 Jun 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260618/26667282.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Dukes Iain D.

Thu, 18 Jun 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260618/26667282.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: WEISER MICHAEL

Thu, 18 Jun 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260618/26667288.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: WEISER MICHAEL

Thu, 18 Jun 2026 17:17:00 -0400

si-local-file:///var/storage/secattach/20260618/26667288.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Maynard Ryan D

Thu, 18 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260618/26667268.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Maynard Ryan D

Thu, 18 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260618/26667268.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Countouriotis Athena

Thu, 18 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260618/26667274.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Countouriotis Athena

Thu, 18 Jun 2026 17:16:00 -0400

si-local-file:///var/storage/secattach/20260618/26667274.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Puri Raj K.

Thu, 18 Jun 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260618/26667257.html

Form 4 IOVANCE BIOTHERAPEUTICS, For: Jun 16 Filed by: Puri Raj K.

Thu, 18 Jun 2026 17:15:00 -0400

si-local-file:///var/storage/secattach/20260618/26667257.html

Form S-8 IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260618/26667126.html

Form S-8 IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 17:05:00 -0400

si-local-file:///var/storage/secattach/20260618/26667126.html

Form S-8 IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260618/26667120.html

Form S-8 IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 17:04:00 -0400

si-local-file:///var/storage/secattach/20260618/26667120.html

Iovance Biotherapeutics (IOVA) files mixed shelf

Thu, 18 Jun 2026 16:32:42 -0400

Iovance Biotherapeutics (NASDAQ: IOVA) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Rights to Purchase Common Stock, Preferred Stock, Debt Securities or Units

Iovance Biotherapeutics (IOVA) files mixed shelf

Thu, 18 Jun 2026 16:32:42 -0400

Iovance Biotherapeutics (NASDAQ: IOVA) has filed mixed shelf of:

Common Stock

Preferred Stock

Debt Securities

Warrants

Units

Rights to Purchase Common Stock, Preferred Stock, Debt Securities or Units

Form S-3ASR IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666624.html

Form S-3ASR IOVANCE BIOTHERAPEUTICS,

Thu, 18 Jun 2026 16:31:00 -0400

si-local-file:///var/storage/secattach/20260618/26666624.html

Form 8-K IOVANCE BIOTHERAPEUTICS, For: Jun 04

Wed, 10 Jun 2026 17:01:00 -0400

si-local-file:///var/storage/secattach/20260610/26630736.html